BELLEVUE, Wash.–(BUSINESS WIRE)–$NVOS #AAPI–Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints providing services and product innovation, today reported its financial results for the fiscal year ended August 31, 2022. Robert Mattacchione, the Company’s CEO … [Read more…]

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–CareTrust REIT, Inc. (NYSE:CTRE) announced today that it has acquired two skilled nursing facilities: AdventHealth Care Center Burleson, a 178-bed facility located in Burleson, Texas, and AdventHealth Care Center Overland Park, a 102-bed facility located in Overland Park, Kansas. The Overland Park facility represents CareTrust’s entry into the Kansas market. The acquisition … [Read more…]

– First treatment option combining an antibody-drug conjugate plus a PD-1 inhibitor in this patient population – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE:4503) today announced the U.S. Food and Drug Administration (FDA) has granted PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) accelerated approval in the U.S. as a combination … [Read more…]

First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv) … [Read more…]

SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (“Legend Biotech” or the “Company”) (NASDAQ: LEGN), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced the formation of a strategic advisory board and the appointments of Michel Vounatsos, former CEO of Biogen Inc., and John Maraganore, PhD, former CEO of Alnylam Pharmaceuticals, … [Read more…]

Agile, a rapidly growing California-based occupational medicine clinic group, has acquired WorkWell and added five locations to its expanding network of occupational medicine clinics, now with 20 clinics. COSTA MESA, Calif.–(BUSINESS WIRE)–Agile announced today that it had completed its acquisition of WorkWell Medical Group in Salinas, California, and will immediately operate their five clinics under … [Read more…]

DALLAS–(BUSINESS WIRE)–Brident Dental & Orthodontics, a member of the Sonrava Health family of wellness companies, today announced the opening of a new Texas office in the city of Keller, located in Tarrant County, northwest of Fort Worth. Located at 681 South Main Street, the new Keller office is the fourth Brident office to open in … [Read more…]

AURORA, Ill.–(BUSINESS WIRE)–Simplify Healthcare is pleased to announce that it ranks No. 159 among the 300 honorees on FORTUNE America’s Most Innovative Companies list. The ranking of America’s Most Innovative Companies is built on three pillars: product innovation, process innovation, and innovation culture. The ranking wants to guide readers on which US companies are at … [Read more…]

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced today that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant Biopharma Ltd., Myovant Sciences, Inc., Urovant Sciences, Inc., Enzyvant Therapeutics, Inc., and Sumitomo Pharma Oncology, Inc. to form Sumitomo Pharma America, Inc. effective July 1, … [Read more…]

Event at the Texas Rangers MLB Youth Academy Features Resources from the American Cancer Society, Parkland Health, UT Southwestern Moncrief Cancer Institute, Los Barrios Unidos Community Clinic and Many Others DALLAS–(BUSINESS WIRE)–In 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases across the United States. In 2023, there will be an … [Read more…]